Medtronic, Inc. Denies Involvement With On-Demand Orgasm Implant

Medtech titan Medtronic says that it's not involved with research on an orgasm-inducing neurostimulation system, despite reports to the contrary. Medical device industry giant Medtronic (NYSE:MDT) told MassDevice.com today that despite reports of the company's participation in upcoming studies, Medtronic is not involved with research on an implantable neurostimulator designed for treatment of sexual dysfunction. Reports have circulated today that Medtronic has signed on to conduct research with physician and inventor Dr. T. Stuart Meloy, who holds a patent on technology that uses traditional nerve stimulation to target nerves in the spine and produce orgasms at the push of a remote-controlled button.

Help employers find you! Check out all the jobs and post your resume.